CGMP/Finished Pharmaceuticals/Adulterated
Similar Posts
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies
This draft guidance describes considerations regarding a comparative clinical study or studies with efficacy endpoints (a comparative efficacy study or CES) intended to support a demonstration that a proposed therapeutic protein product is biosimilar to a reference product.Angiographic Catheter Recall: Cook Removes Beacon Tip Angiographic Catheters due to Tip Separation
Affected device lots may experience tip separation; field complaints reported that the tip separation can occur both prior to and during patient contact.Ongoing | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.Hofood99 Inc Recalls Enoki Mushroom Due to Possible Health Risk
Hofood99 Inc of Brooklyn, NY 11231 is recalling its 200g packages of Enoki Mushroom, because they may be contaminated with Listeria monocytogenesFDA Listing of Authorized Generics
FDA Listing of Authorized GenericsMAMTAKIM Inc Recalls Dried Whole Smelts Salted (KORUSHKA) Because of Possible Health Risk
MAMTAKIM Inc, located at 888 Magnolia Ave, Elizabeth, NJ 07201, is recalling Item # LL0320 DRIED WHOLE SMELTS SALTED (KORUSHKA), 5.29 oz (150 g) / 20 – 1 box, because this product consists of dried, un eviscerated fish longer than 5 inches, which has the potential to be contaminated with Clostridium